PRESS RELEASE published on 02/16/2026 at 07:00, 1 month 6 days ago Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season Universal RSV immunization with Beyfortus reduces hospitalizations in infants across two seasons, as per study in The Lancet Infectious Diseases and RSVVW '26 conference findings RSV Beyfortus Infants Immunization Hospitalizations
BRIEF published on 02/10/2026 at 15:05, 1 month 12 days ago Sanofi finalise l'acquisition de Dynavax Acquisition Biopharma Sanofi Vaccins Dynavax
BRIEF published on 02/10/2026 at 15:05, 1 month 12 days ago Sanofi Finalizes Acquisition of Dynavax Acquisition Biopharma Sanofi Vaccines Dynavax
PRESS RELEASE published on 02/10/2026 at 15:00, 1 month 12 days ago Communiqué de presse : Sanofi finalise l’acquisition de Dynavax Sanofi finalise l’acquisition de Dynavax, renforçant ainsi sa présence dans le domaine de la vaccination des adultes. L'acquisition inclut le vaccin contre l’hépatite B pour adultes HEPLISAV-B et le vaccin candidat contre le zona de Dynavax Acquisition Sanofi Vaccination Dynavax Adultes
PRESS RELEASE published on 02/10/2026 at 15:00, 1 month 12 days ago Press Release: Sanofi completes the acquisition of Dynavax Sanofi completes acquisition of Dynavax, bolstering presence in adult immunization with HEPLISAV-B vaccine and Z-1018 shingles vaccine candidate, enhancing global reach and development capabilities Acquisition Sanofi Vaccine Immunization Dynavax
BRIEF published on 02/03/2026 at 07:05, 1 month 19 days ago Sanofi Signs €1 Billion Share Buyback Mandate Share Buyback Investment Financial Strategy Biopharma Sanofi
BRIEF published on 02/03/2026 at 07:05, 1 month 19 days ago Sanofi signe un mandat de rachat d'actions de 1 milliard d'euros Investissement Rachat D'actions Stratégie Financière Biopharma Sanofi
PRESS RELEASE published on 02/03/2026 at 07:00, 1 month 19 days ago Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion Sanofi signs share buyback mandate for up to €1 billion, intending to repurchase own shares between February 3, 2026, and December 31, 2026 Share Buyback Investment Sanofi Mandate €1 Billion
BRIEF published on 01/30/2026 at 13:05, 1 month 23 days ago The CHMP recommends approval of Sanofi's Rezurock for the treatment of chronic GVHD Treatment Sanofi Rezurock CHAMP GVHD
BRIEF published on 01/30/2026 at 13:05, 1 month 23 days ago Le médicament Rezurock de Sanofi est recommandé pour une approbation européenne par le CHMP. Sanofi Marché De L'UE Rezurock Approbation CHMP GVHD Chronique
Published on 03/20/2026 at 13:30, 2 days 10 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 11 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 11 hours 37 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 1 hour ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 2 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 2 days 2 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 19:00, 2 days 5 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 5 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 5 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 5 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA